ライフサイエンスコーパス: angiography

1 ed workstation (Three-Dimensional Rotational Angiography).

2 59 [74%] at initial and 21 [26%] at later CT angiography).

3 -resolved optical coherence tomography (OCT) angiography.

4 rge cohort of patients referred for coronary angiography.

5 signal in the deep capillary plexuses in OCT angiography.

6 nts with ASA sensitivity undergoing coronary angiography.

7 on of obstructive coronary artery disease by angiography.

8 rosclerotic culprit lesion identified during angiography.

9 easured in 3278 patients undergoing coronary angiography.

10 al cerebral hemisphere on CT and MRI dynamic angiography.

11 nd the LMCA and underwent selective coronary angiography.

12 Ns in preclinical MRI and magnetic resonance angiography.

13 received ECLS, and all 55 received coronary angiography.

14 determined by coronary computed tomographic angiography.

15 studied patients who underwent MSCT coronary angiography.

16 a simultaneous fluorescein/indocyanine green angiography.

17 raphy that were not mirrored by conventional angiography.

18 ompared with expert placement on coronary CT angiography.

19 t-degree relatives using computed tomography angiography.

20 ic computed tomography or magnetic resonance angiography.

21 aging and coronary computed tomographic (CT) angiography.

22 as measured by coronary computed tomographic angiography.

23 tomography, and optical coherence tomography angiography.

24 ed macular edema, and leakage on fluorescein angiography.

25 with lesions identified on indocyanine green angiography.

26 s observed for diagnosing carotid webs at CT angiography.

27 ardized multiphase computed tomographic (CT) angiography.

28 diameter stenosis after 6 months measured by angiography.

29 eath, and need for transfusions, surgery, or angiography.

30 re with lower risk and cost than fluorescein angiography.

31 s was evaluated at computed tomographic (CT) angiography.

32 Of these, 17 141 (65%) underwent coronary angiography, 12 183 (46.2%) underwent percutaneous coron

33 Coronary angiography (314 [35.0%] vs 925 [60.8%]; P < .001) and P

34 Furthermore, for diagnostic coronary angiography 5F instead of 4F introducer was used.

35 ing and partial volume effects of routine CT angiography acquisitions to produce accurate quantificat

36 tery disease on subsequent invasive coronary angiography across CAC score strata (Agatston score: 0,

37 esonance angiography or computed tomographic angiography after equivocal 2D ultrasound results.

38 9, 43% women) referred for invasive coronary angiography after stress testing with myocardial perfusi

39 y the split-spectrum amplitude-decorrelation angiography algorithm.

40 l mortality benefit compared with diagnostic angiography alone.

41 AVR, screening of CAD with invasive coronary angiography and ad hoc PCI during TAVR is feasible and w

42 el clinical trial using the Swedish Coronary Angiography and Angioplasty Registry for enrollment.

43 from the nationwide SCAAR (Swedish Coronary Angiography and Angioplasty Registry).

44 artery M1 and/or M2) on computed tomographic angiography and baseline ischemic core greater than 50 m

45 years, 52% women) were included via coronary angiography and computed tomography as part of the TWIST

46 e laboratory performed quantitative coronary angiography and evaluated all pressure tracings.

47 total of 239 cross sections obtained with CT angiography and histologic examination were matched.

48 ic assessment provided with both coronary CT angiography and ICA has poor discriminatory power for is

49 ge of Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surge

50 D Serial (baseline and 6-12 months) coronary angiography and intravascular ultrasound were performed

51 gh-resolution computed tomographic pulmonary angiography and Ki-67 immunohistochemistry revealed abun

52 Retinal fluorescein angiography and optical coherence tomography (OCT) revea

53 Longitudinal quantitative vascular angiography and optical coherence tomography were perfor

54 ent diagnostic methods, such as fluorescence angiography and optical coherence tomography, remain con

55 on, timely reperfusion, and postfibrinolysis angiography and PCI.

56 utaneous Coronary Intervention) for coronary angiography and percutaneous coronary intervention (667,

57 ned to radial or femoral access for coronary angiography and percutaneous intervention, and collected

58 delivery was calculated using phase contrast angiography and pre-ductal pulse oximetry, while regiona

59 Subsequent rates of coronary angiography and revascularization after stress testing w

60 increased fractional hypoxia 24 hours after angiography and stenting in placebo (+47%) versus elamip

61 ly detected on coronary computed tomographic angiography and strongly associated with adverse events

62 CT angiography and TAE represent the methods of choice for

63 and diagnostic accuracy were assessed at CT angiography and were compared with those attained with I

64 70 mm Hg at second screening underwent renal angiography and were randomly assigned to renal denervat

65 d of having atherosclerosis who underwent CT angiography and were referred for endarterectomy were en

66 orescein angiography, hypofluorescent on ICG angiography, and correlated with choroidal lesions on SD

67 early onset, cuticular drusen on fluorescein angiography, and family history of AMD.

68 ted, only 5.9% underwent subsequent coronary angiography, and only 3.1% underwent repeat revasculariz

69 bevacizumab, fundus photographs, fluorescein angiography, and optical coherence tomography.

70 ECLS, coronary angiography, and percutaneous coronary intervention were

71 (r = 0.87; P = .003) on computed tomographic angiography, and this relationship held when we controll

72 ry network with optical coherence tomography angiography (angio-OCT) in morning glory syndrome (MGS),

73 laparoscopy, endoscopy, computed tomographic angiography, angiographic intervention, serial imaging,

74 Catheter angiography appears to be unhelpful, suggesting that cla

75 Computed tomography, ultrasound Doppler and angiography are the main diagnostic tools used for the d

76 terpreted coronary computed tomographic (CT) angiography as part of the clinical evaluation of stable

77 ome of patients with ACS undergoing coronary angiography, as compared with patients with stable coron

78 P), OCT, blue light reflectance, fluorescein angiography, as well as fundus photography, were also re

79 ravascular ultrasound (IVUS) or conventional angiography at a large single center.

80 ntified by phase contrast magnetic resonance angiography at baseline and after 120 min.

81 -based strategy compared with a conventional angiography-based approach.

82 ctively defined management strategy based on angiography before performing FFR.

83 or fundus photography and fluorescein fundus angiography, before and immediately after cutting the PC

84 embolism (PE) and who underwent CT pulmonary angiography between January 1, 2011, and August 31, 2013

85 central core laboratory also interpreted CT angiography blinded to clinical data, site interpretatio

86 was quantified in each subject via coronary angiography by calculating a CAD score.

87 ease (CAD) was defined as >/=50% stenosis on angiography by core laboratory.

88 the presence of CAV at the time of coronary angiography by using multivariate logistic regression mo

89 ought to evaluate the diagnostic accuracy of angiography by visual estimate and by quantitative coron

90 on patients' radiation doses during coronary angiography (CA) and PCI and temporal trends are lacking

91 Acute Coronary Events) score >140, coronary angiography (CAG) is recommended by European and America

92 Conclusion Multiphase CT angiography can help differentiate among different forms

93 raphy (PET) and coronary computed tomography angiography (CCTA) is predominantly used for this purpos

94 ized to receive coronary computed tomography angiography (CCTA) vs functional testing.

95 AS) using cardiovascular computed tomography angiography (CCTA).

96 on arrival, (2) perform computed tomographic angiography concurrently with noncontract computed tomog

97 rence tomography (OCT), and with fluorescein angiography confirmation.

98 Angiography confirmed a complete exclusion of the aneury

99 with conventional computed tomographic (CT) angiography could be quantitated at higher levels of acc

100 CSA during coronary angiography could effectively remove more than one third

101 e subjected to CSA procedure during coronary angiography (CSA group), and 25 patients served as a con

102 ndergone computed tomography and/or cerebral angiography (CT/angio) studies had a higher risk of deve

103 which a RH computed tomography (CT) and a CT angiography (CTA) at arrival were available for review.

104 Two weeks later, computed tomographic angiography (CTA) confirmed persistent aneurysmal perfus

105 ing with either coronary computed tomography angiography (CTA) or functional testing (exercise electr

106 The computed tomographic angiography (CTA) spot sign is associated with intracere

107 c assessment of coronary computed tomography angiography (CTA).

108 ardiography) or coronary computed tomography angiography (CTA).

109 screening with computed tomography coronary angiography (CTCA), and assess the safety and efficacy o

110 However, contrast-enhanced CT pulmonary angiography (CTPA) has shown promising results, as the v

111 Dye angiography demonstrated a well-defined hyperfluorescent

112 atures in optical coherence tomography (OCT) angiography depends on accurate segmentation of retinal

113 Angiography-derived FFR measurements (FFRangio) may have

114 Intra-arterial digital subtraction angiography did not identify any underlying causal lesio

115 sults were compared with digital subtraction angiography (DSA) as the reference standard.

116 Digital subtraction angiography (DSA) of cerebral vessels with rotational sc

117 timation (DSVE) and by quantitative coronary angiography (DSQCA) was compared with FFR.

118 gina (n = 33 901) who did or did not receive angiography during their first hospitalization were bala

119 ement pathway initiated by invasive coronary angiography during their hospitalization and up to 2 mon

120 They underwent coronary angiography, endothelial function testing; measurements

121 DS AND In the long-term CONFIRM (Coronary CT Angiography Evaluation For Clinical Outcomes: An Interna

122 ateral ICA nonattenuation at single-phase CT angiography, even specialized radiologists may not relia

123 an optical coherence tomography system with angiography extension and an all optical photoacoustic t

124 compared to the gold standard of fluorescein angiography (FA) and OCT was determined for structural S

125 Fluorescein angiography (FA) may become necessary to evaluate for NV

126 Fluorescein angiography (FA) showed nonspecific retinal inflammation

127 Digital retinal imaging and fluorescein angiography (FA) were performed at an average of 4 years

128 including structural OCT, OCT-A, fluorescein angiography (FA), and indocyanine green angiography (ICG

129 phology on digital color images, fluorescein angiography (FA), and optical coherence tomography (OCT)

130 Imaging features obtained using fluorescein angiography (FA), indocyanine green angiography (ICGA),

131 s photography, autofluorescence, fluorescein angiography (FA), optical coherence tomography (OCT) of

132 undus autofluorescence (FAF) and fluorescein-angiography (FA).

133 fundus photography (FP), fundus fluorescein angiography (FFA), and optical coherence tomography (OCT

134 orescein angiography/indocyanine green (ICG) angiography findings, of patients with a disseminated M.

135 3 patients undergoing routine coronarography angiography for CAV diagnosis (median 5 years since HT).

136 assess the diagnostic value of MDCT coronary angiography for evaluation of acute chest pain of corona

137 FAME 2 trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) compared PCI gui

138 E 1 and 2 trials (Fractional Flow Reserve or Angiography for Multivessel Evaluation).

139 rwent elective coronary computed tomographic angiography for suspected CAD and were followed for 5 ye

140 ients underwent coronary computed-tomography angiography for total coronary plaque burden and NCB qua

141 oxytol-enhanced (FE) magnetic resonance (MR) angiography for vascular mapping before transcatheter ao

142 ges, Optical coherence tomography (OCT), OCT-Angiography, fundus autofluorescence (FAF) and fluoresce

143 ed lower in the IVUS-guided group versus the angiography-guided (6.9% vs. 8.4%, p = 0.22) although th

144 Adding angiography-guided laser photocoagulation to this dosing

145 on (TREX; n = 60), and treat and extend with angiography-GuIded macular LAser photocoagulation (GILA;

146 Eyes in the GILA cohort also received angiography-guided macular laser photocoagulation at mon

147 osing of ranibizumab 0.3 mg with and without angiography-guided macular laser photocoagulation signif

148 Women referred for coronary angiography had a significantly lower burden of obstruct

149 onfirmed LMCA stenosis on selective coronary angiography had PCI.

150 Fluorescein angiography had the highest accuracy (97%, 34 of 35 eyes

151 Coronary computed tomographic (CT) angiography has emerged as a noninvasive method for dire

152 artery disease and guide treatment, coronary angiography has many known limitations, particularly the

153 Fluorescein angiography has shown potentially serious and long-term

154 f routine versus selective invasive coronary angiography have high rates of crossover from control to

155 nts and were hyperfluorescent on fluorescein angiography, hypofluorescent on ICG angiography, and cor

156 fibrillation (AF) by using invasive coronary angiography (ICA) as the reference method and to compare

157 Invasive coronary angiography (ICA) with measurement of fractional flow re

158 Indocyanine-green angiography (ICG-A) may be considered at baseline under

159 orescein angiography (FA), indocyanine green angiography (ICGA), structural optical coherence tomogra

160 cein angiography (FA), and indocyanine green angiography (ICGA).

161 tocol included a calcium scan followed by CT angiography if the Agatston calcium score was between 1

162 mass was quantified on computed tomographic angiography images as tissue with Hounsfield Units betwe

163 ology fellows, independently reviewed the CT angiography images to assess whether there was true cerv

164 Ultra-widefield fluorescein angiography images were obtained in 63 eyes with ischemi

165 omography, fluorescein and indocyanine green angiography in a 66 years old man suffering visual loss.

166 Moreover, magnetic resonance angiography in both AMS and non-AMS subjects showed a si

167 CENT trial (Calcium Imaging and Selective CT Angiography in Comparison to Functional Testing for Susp

168 egions on optical coherence tomography (OCT) angiography in eyes with primary angle closure (PAC) and

169 rrode CDS alerts (by performing CT pulmonary angiography in patients with a Wells score </=4 and a no

170 e study is to emphasize the role of 128 MSCT angiography in the diagnosis of congenital cyanotic hear

171 ordering computed tomographic (CT) pulmonary angiography in the emergency department (ED).

172 rt, we discuss and illustrate the role of CT angiography in the evaluation of acute, active gastroint

173 e of tibial artery and pedal arch patency by angiography in these patients.

174 Patients underwent multiphase CT angiography in three automated phases after injection of

175 c recommendations exist regarding the use of angiography in unstable angina.

176 [European Ambulance Acute Coronary Syndrome Angiography]) included 2198 patients with STEMI undergoi

177 ded by FFR, divergent from that suggested by angiography, including revascularization deferral, is sa

178 mbinations of color photography, fluorescein angiography, indocyanine green angiography, near-infrare

179 ndus autofluorescence (FAF), and fluorescein angiography/indocyanine green (ICG) angiography findings

180 e segmentation of retinal layers among 3 OCT angiography instruments in the central macula, an area w

181 ence of hypodense veins in the monophasic CT angiography ipsilateral to the arterial occlusion.

182 Optical coherence tomography angiography is a noninvasive vascular imaging modality t

183 Optical coherence tomographic angiography is a novel imaging modality to quantify the

184 The predictive accuracy of angiography is moderate in patients with </=1 RFs, but w

185 ion is often difficult and invasive coronary angiography is performed routinely.

186 ranscatheter aortic valve replacement, FE MR angiography is technically feasible and offers reliable

187 sk factors impact the diagnostic accuracy of angiography is unknown.

188 Optical coherence angiography may be indicated to identify this complicati

189 n were used to assess the reliability of OCT angiography measurements.

190 , fluorescein angiography, indocyanine green angiography, near-infrared reflectance, fundus autofluor

191 The yield of CT pulmonary angiography (number of positive PE diagnoses/total numbe

192 y (SD-OCT), and optical coherence tomography angiography (OCT-A) detect more-frequent retinopathy in

193 of 7 different optical coherence tomography angiography (OCT-A) devices by comparing vessel density

194 s identified by optical coherence tomography angiography (OCT-A) in patients with various sickle cell

195 Optical coherence tomographic angiography (OCT-A) is able to visualize retinal microva

196 optical coherence tomography (OCT), and OCT angiography (OCT-A) were noted at first presentation and

197 To compare optical coherence tomography angiography (OCT-A) with traditional multimodal imaging

198 MD) by means of optical coherence tomography angiography (OCT-A).

199 ings, including optical coherence tomography angiography (OCT-A).

200 Optical coherence tomography angiography (OCTA) allows visualization of iris racemose

201 eneration using optical coherence tomography angiography (OCTA) and adaptive optics scanning laser op

202 in of PCV using optical coherence tomography angiography (OCTA) and multiple image systems.

203 ion (AMD) using optical coherence tomography angiography (OCTA) and study its correlation to visual a

204 making during vitreoretinal surgery, and OCT angiography (OCTA) has provided novel insights in clinic

205 ng noninvasive optical coherence tomographic angiography (OCTA) have measured blood flow in the retin

206 s and underwent optical coherence tomography angiography (OCTA) imaging with follow-up greater than 1

207 l density using optical coherence tomography angiography (OCTA) in eyes with central retinal vein occ

208 asculature with optical coherence tomography angiography (OCTA) in malignant iris melanomas and benig

209 mography (SDOCT) with their detection on OCT angiography (OCTA) in patients with nonproliferative dia

210 specificity of optical coherence tomography angiography (OCTA) in the detection of choroidal neovasc

211 Optical coherence tomography angiography (OCTA) is a noninvasive method of 3D imaging

212 f adults with vitreoretinal disease, and OCT angiography (OCTA) is demonstrating promise as a techniq

213 ments based on optical coherence tomographic angiography (OCTA) may have value in managing diabetic r

214 ticipant was imaged using 6x6-mm macular OCT angiography (OCTA) scan pattern by 70-kHz 840-nm spectra

215 extra-vascular optical coherence tomography angiography (OCTA) signals corresponding to hyperreflect

216 ion (MNV) using optical coherence tomography angiography (OCTA) with a projection artifact removal al

217 tofluorescence, optical coherence tomography angiography (OCTA), and automated quantification of the

218 Optical coherence tomography angiography (OCTA), if optimized, could make the imaging

219 sculature using optical coherence tomography angiography (OCTA).

220 oma (CM), using optical coherence tomography angiography (OCTA).

221 izontal, vertical, and en face sections; OCT angiography of the 6 x 6-mm perifoveal retina; 30 degree

222 easured by phase-contrast magnetic resonance angiography of the cerebropetal vessels.

223 MDCT angiography of the coronaries is a good and rapid method

224 early CSC notification, computed tomographic angiography on arrival to the PSC, and cloud-based image

225 To assess the effect of angiography on mortality in unstable angina, incorporati

226 n, and carotid artery evaluation (by Doppler/angiography) on the side of ocular arterial occlusion, a

227 viders followed Wells criteria (CT pulmonary angiography only in patients with Wells score >4 or </=4

228 confirmatory testing with magnetic resonance angiography or computed tomographic angiography after eq

229 pacification and Heart Rhythm in Coronary CT Angiography, or IsoCOR, trial.

230 Compared with coronary angiography performed soon after recanalization of the c

231 ase of critical hand ischemia after coronary angiography performed through radial access despite exis

232 They underwent ICA and coronary CT angiography performed with a whole-heart CT scanner.

233 Angiography, performed in 1126 patients, showed obstruct

234 m CT (PMCT), enhanced with targeted coronary angiography (PMCTA), in adults to avoid invasive autopsy

235 y, a harm of screening included the risk for angiography prompted by abnormal results on carotid ultr

236 Coronary computed tomographic angiography provided significantly better prognostic inf

237 Dynamic time-resolved contrast-enhanced MR angiography provides information regarding hemodynamics

238 ization of other stress modalities, coronary angiography, reduced smoking, and greater utilization of

239 ld stereo fundus photography and fluorescein angiography, respectively.

240 Ninety-day quantitative vascular angiography results showed a lower percent diameter sten

241 used to evaluate the likelihood of coronary angiography, revascularization, and in-hospital mortalit

242 fects of this exclusion on rates of coronary angiography, revascularization, and mortality among pati

243 CT angiography revealed a single bronchial artery aneurysm

244 oidal vessels and optic atrophy; fluorescein angiography revealed gradual restoration of the choroida

245 CT coronary angiography revealed positive coronary artery disease fi

246 A) prototype system or a spectral-domain OCT angiography (SD-OCTA) prototype system.

247 -embolization assessment of bleeding with CT angiography shortens the total diagnostic time, which re

248 METHODS AND When invasive coronary angiography showed CAD, the treatment strategy and compl

249 The projection-resolved OCT angiography showed good within-session baseline repeatab

250 In 83 patients (13.8%), coronary angiography showed severe CAD that was left untreated.

251 Fluorescein fundus angiography soon after cutting the PCAs showed no fillin

252 otography, fluorescein and indocyanine green angiographies, spectral-domain optical coherence tomogra

253 s, including fundus photography, fluorescein angiography, spectral-domain optical coherence tomograph

254 cluded fundus color photographs, fluorescein angiography, spectral-domain optical coherence tomograph

255 ng swept-source optical coherence tomography angiography (SS-OCTA) and en-face image analysis.

256 were imaged using either a swept-source OCT angiography (SS-OCTA) prototype system or a spectral-dom

257 underwent thrombectomy with preprocedural CT angiography that helps to demonstrate a lack of attenuat

258 ary artery disease detected on MDCT coronary angiography that were not mirrored by conventional angio

259 e registry of patients referred for coronary angiography, the goal of this study was to develop a cli

260 Results The later the phase of CT angiography, the higher the frequency of the spot sign.

261 At 6 months angiography, the percent diameter stenosis was significa

262 for renal complications who were undergoing angiography, there was no benefit of intravenous sodium

263 and reliability of computed tomographic (CT) angiography to distinguish true cervical internal caroti

264 ble symptomatic women who underwent coronary angiography to evaluate symptoms and signs of ischemia.

265 Use projection-resolved OCT angiography to investigate the autoregulatory response i

266 r renal complications who were scheduled for angiography to receive intravenous 1.26% sodium bicarbon

267 to determine if ultra-widefield fluorescein angiography (UWFA), spectral-domain optical coherence to

268 Unselected Population Referred for Invasive Angiography [VERIFY2]; NCT02377310).

269 The yield of CT pulmonary angiography was 4.2% in the override group (25 of 589 st

270 Projection-resolved OCT angiography was able to show that the retinal autoregula

271 Routine angiography was associated with a 52% decrease in 12-mon

272 Each CT order for pulmonary angiography was exposed to CDS on the basis of the Wells

273 The diagnostic yield of invasive coronary angiography was highest in patients with CAC>400 (87% ve

274 FE MR angiography was performed at 3.0 T or 1.5 T.

275 ls and Methods Contrast material-enhanced MR angiography was performed in baboons (Papio anubis; n =

276 though cases frequently mimicked vasculitis, angiography was uniformly negative, and spinal imaging f

277 ter stenosis >/=80% on quantitative coronary angiography was used as reference standard to define isc

278 ardiography and coronary computed tomography angiography, we assessed 3 primary outcome measures: lef

279 With ultra-widefield angiography, we have ascertained that posterior pole non

280 l coherence tomography (OCT) and fluorescein angiography were also obtained at some visits.

281 Reviewers of angiography were blinded to results of physiological tes

282 Findings at FE MR angiography were compared with pelvic angiograms.

283 g features with computed tomography scan and angiography were highly suggestive.

284 te baseline CT perfusion study who underwent angiography were included (mean age = 66 years, median N

285 ithout AF who underwent computed tomographic angiography were included.

286 Results from coronary CT angiography were not included, and diagnostic performanc

287 visual estimate and by quantitative coronary angiography when compared with FFR and evaluate the infl

288 systemic shunting was demonstrated by portal angiography, which disclosed virtually complete portosys

289 diagnosis was established based on selective angiography, which was followed by transcatheter arteria

290 e eyes with CRVO imaged with ultra-widefield angiography with a minimum of 12 months follow-up.

291 lusion Mn-PyC3A enables contrast-enhanced MR angiography with comparable contrast enhancement to gado

292 The median time to the end of angiography with CS was 104 minutes (IQR, 75-150 minutes

293 tation, with indications to undergo coronary angiography with intent to perform percutaneous coronary

294 story of ASA sensitivity undergoing coronary angiography with intent to undergo percutaneous coronary

295 and if IA therapy is considered noninvasive, angiography with one of these modalities is necessary to

296 f patients undergoing coronary or peripheral angiography with or without intervention was prospective

297 (CI, 0.021 to 0.027) for patients receiving angiography within 2 months of their index unstable angi

298 o analyzed a subgroup who underwent coronary angiography within 30 days after positive DSE.

299 Results Twenty-six patients underwent FE MR angiography without adverse events.

300 injury and associated adverse outcomes after angiography without definitive evidence of their efficac